Talasaz AmirAli

Co-Chief Executive Officer

Talasaz AmirAli has filed 12 SEC Form 4 filings (64 transaction rows) across 1 company, with disclosures dating back to 2025. 11 of those filings fall inside the rolling window. Most recent filing: Oct 2, 2026.

On the most recent filing, Talasaz AmirAli is listed as Co-Chief Executive Officer at Guardant Health, Inc. Inside the rolling window, Talasaz AmirAli reported no open-market purchases and 6 open-market sales totaling $79.0M in GH. The largest disclosed transaction in the window is a sale of 210,000 GH shares on May 20, 2026, worth $23.1M.

Companies traded

Other insiders at GH

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$79.0M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
GHSale$6.3MAug 24SEC ↗
GHSale$17.6MJun 30SEC ↗
GHSale$21.7MJun 30SEC ↗
GHSale$23.1MMay 22SEC ↗
GHSale$5.0MMay 13SEC ↗
GHSale$5.3MDec 10SEC ↗
Showing 1–6 of 6
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Talasaz AmirAli made?

Talasaz AmirAli has filed 12 SEC Form 4 filings (64 transaction rows) across 1 company since 2025.

Which companies does Talasaz AmirAli trade?

Talasaz AmirAli has filed SEC Form 4 disclosures for 1 company, including GH.

When was Talasaz AmirAli's most recent SEC Form 4 filing?

Talasaz AmirAli's most recent SEC Form 4 filing on Tracefour is dated Oct 2, 2026.

What is Talasaz AmirAli's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Talasaz AmirAli is listed as Co-Chief Executive Officer.

What is Talasaz AmirAli's total buy and sell value in the current window?

Inside the rolling retention window, Talasaz AmirAli bought $0 and sold $79.0M based on SEC Form 4 filings.

What was Talasaz AmirAli's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 210,000 GH shares on 2026-05-20, worth $23.1M, per SEC Form 4 filings.